Signs of Life in Boston Biotech CRE
Little tiny green shoots are poking up here and there, with leasing activity running well ahead of 2024 totals and the pace of vacancy growth slowing down.
Don’t Bet on Filling Those Lab Buildings Any Time Soon
The Bay State’s life sciences sector now faces the prospect of a potential retrenchment amid slashing cuts to research funding and drops in venture capital funding.
Life Science Market Fundamentals Show Advantage Lies with Users
Dour-sounding statistics about the state of Massachusetts’ life science real estate market should be put into context. Yes, the market has short-term challenges, but it will normalize over the coming years.
Funding Climate Clouds Biotech Growth Trajectory
The Boston metro has been a leader in life science research for decades, and while its upward trajectory continued so far this year, a few headwinds are mounting.
Blackstone Buys Cambridge-Focused Portfolio for $3.45B
Blackstone Property’s life science arm will become the largest landlord in the industry’s Cambridge hub with the pending $3.45 billion acquisition of a 2.3-million-square-foot office-lab portfolio from Brookfield Asset Management.
